ADLVX | VMVAX | ADLVX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 6 years | 13 years | - |
Gain YTD | 17.381 | 19.623 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.07M | 30.9B | 0% |
Annual Yield % from dividends | 1.12 | 2.14 | 52% |
Returns for 1 year | 27.79 | 28.25 | 98% |
Returns for 3 years | 2.84 | 16.94 | 17% |
Returns for 5 years | 49.81 | 50.95 | 98% |
Returns for 10 years | N/A | 98.29 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMRX | 19.36 | 0.31 | +1.63% |
Voya Mid Cap Research Enhanced Index C | |||
OFAVX | 29.88 | 0.32 | +1.08% |
Olstein All Cap Value A | |||
NBSTX | 50.86 | 0.28 | +0.55% |
Neuberger Berman Sustainable Equity Tr | |||
RYCEX | 89.49 | 0.16 | +0.18% |
Rydex Europe 1.25x Strategy C | |||
TREPX | 13.67 | 0.01 | +0.07% |
Nuveen International Eq Premier |